APA (7th ed.) Citation

Feng, D., Yan, Z., Fu, B., Bai, S., Zhu, L., Gale, R. P., . . . Wang, H. Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Feng, Demei, Zhimin Yan, Bibo Fu, Shenrui Bai, Lewei Zhu, Robert Peter Gale, Zhongjun Xia, Yang Liang, and Hua Wang. Phase II Study of Pegaspargase, Etoposide, Gemcitabine (PEG) Followed by Involved-field Radiation Therapy in Early-stage Extranodal Natural Killer/T-cell Lymphoma. Taylor & Francis Group.

MLA (9th ed.) Citation

Feng, Demei, et al. Phase II Study of Pegaspargase, Etoposide, Gemcitabine (PEG) Followed by Involved-field Radiation Therapy in Early-stage Extranodal Natural Killer/T-cell Lymphoma. Taylor & Francis Group.